PRCS - Praecis Pharmaceuticals Inc
NYSE * Health Care * Biotechnology
$26.42
$-0.38 (-1.42%)
About Praecis Pharmaceuticals Inc
The fund is an actively managed ETF whose objective is to achieve capital appreciation by investing primarily in a concentrated portfolio of equity securities. Equity securities include common and preferred stock. Under normal circumstances, the fund will invest a minimum of 80% of its net assets (plus borrowings for investment purposes) in equity securities selected using its core strategy. The fund is non-diversified.
PRCS Key Statistics
Market Cap
$0.00M
How PRCS Compares to Peers
P/E Rank
N/A
of 5
Margin Rank
N/A
of 5
Growth Rank
N/A
of 5
Size Rank
N/A
of 5
Praecis Pharmaceuticals Inc Company Information
- Headquarters
- Massachusetts; U.S.A
- Sector
- Health Care
- Industry
- Biotechnology